1Zeng Q, Chen S, You Z, et al. Hepatocyte growth factor inhibits anoikis in head and neck squamous cell carcinoma cells by activation of ERK and Akt signaling independent of NF-кB [ J]. J Biol Chem, 2002,277(28): 25203-25208.
2Hubbard SR, Mohammadi M, Schlessinger J. Autoregulatory mechanisms in protein-tyrosine kinases [ J ]. J Biol Chem, 1998,273(20) :11987-11990.
3Bardelli A, Longati P, Williams TA, et al. A peptide representing the carboxyl-terminal tail of the met receptor inhibits kinase activity and invasive growth[ J]. J Biol Chem,1999,274(41 ):29274.
4Recio JA and Merlino G. Hepatocyte growth factor/scatter factor activates proliferation in melanoma cells through p38 MAPK, ATF-2 and cyclin D1 [J]. Oncogene, 2002,21(7):1000-1008.
5Paumelle R, Tulasne D, Kherrouche Z, et al. Hepatocyte growth factor/scatter factor activates the ETS1 transcription factor by a RAS-RAF-MEK-ERK signaling pathway [ J ]. Oncogene, 2002,21(15) :2309-2319.
6Nakajima M, Sawada H, Yamada Y, et al. The prognostic significance of amplification and overexpression of c-met and c-erb B-2 in human gastric carcinomas [ J ]. Cancer, 1999,85 ( 9 ) : 1894 - 1902.
7Chen BK, Ohtsuki Y, Furihata M, et al. Overexpression of c-Met protein in human thyroid tumors correlated with lymph node metastasis and clinicopathologic stage [ J]. Pathol Res Pract, 1999, 195(6) :427-433.
8Ghoussoub RA, Dillon DA, D'Aquila T, et al. Expression of c-met is a strong independent prognostic factor in breast carcinoma [ J ].Cancer,1998,82 ( 8 ) 11513-1520.
9Maehara N, Matsumoto K, Kuba K, et al. NK4, a four-kringle antagonist of HGF, inhibits spreading and invasion of human pancreatic cancer cells[J]. Br J Cancer, 2001,84(6) :864-873.
10Horikawa T, Sheen TS, Takeshita H, et al. Induction of c-Met proto-oncogene by Epstein-Barr virus latent membrane protein-1 and the correlation with cervical lymph node metastasis of nasopharyngeal carcinoma[J]. Am J Pathol, 2001,159( 1 ) :27-33.
